Science & Research FDA OKs Drug Offering Hope for HUS Treatment A drug that holds significant promise for treating the devastating effects of hemolytic uremic syndrome (HUS) has been approved for limited use, the U.S. Food and Drug Administration announced By Mary Rothschild / 23 Sep 2011